1Brannon-Peppas L,Blanchette JO.Nanoparticle and targeted systems for cancer therapy[J].Adv Drug Deliv Rev,2004,56(11):1649-1659.
2Ferrari M.Cancer nanotechnology:opportunities and challenges[J].Nat Rev Cancer,2005,5(3):161-171.
3Whitesides GM.The 'right' size in nanobiotechnology[J].Nat Biotechnol,2003,21(10):1161-1165.
4Allen TM.Ligand-targeted therapeutics in anticancer therapy[J].Nat Rev Cancer,2002,2(10):750-763.
5Hirsch LR,Stafford RJ,Bankson JA,et al.Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance[J].Proc Natl Acad Sci USA,2003,100(23):13549-13554.
6Tolson J,Bogumil R,Brunst E,et al.Serum protein profiling by SELDI mass spectrometry:detection of multiple variants of serum amyloid alpha in renal cancer patients[J].Lab Invest,2004,84(7):845-856.
7Cai D,Mataraza JM,Qin ZH,et al.Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing[J].Nat Methods,2005,2(6):449-454.
8Will O,Purkayastha S,Chan C,et al.Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases:a meta-analysis[J].Lancet Oncol,2005,7:52-60.
9Kobayashi H,Kawamoto S,Sakai Y,et al.Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent[J].J Natl Cancer Inst,2004,96(9):703-708.
4Fernandez-Madrid F, Tang N, Alansari H, et al. Autoantibodies to Annexin XI-A and other autoantigens in the diagnosis of breast cancer [J]. Cancer Res,2004,64(15):5089-5096.
